Raj Chovatiya, MD, PhD: Atopic Dermatitis Update 2023

In a recap of his Maui Derm NP+PA Fall 2023 session, Dr. Chovatiya discusses the array of new drug approvals for AD, including biologics, oral drugs, and topicals, and how to choose between each option for our patients with AD.


Dr. Harper recaps her session from Maui Derm NP+PA Fall, in which she discussed moving away from rosacea subtypes as well as new insights in rosacea pathogenesis and treatment. ...